drugset
drugset / Trial / NCT00427245

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

NCT00427245 ↗

Phase 3 Completed 400 enrolled Anglo Celtic Cooperative Oncology Group
RandomizedOpen-labelSupportive care

Summary

RATIONALE: Goserelin may help prevent early menopause in patients undergoing chemotherapy for breast cancer. It is not yet known whether goserelin is effective in preventing early menopause in women undergoing chemotherapy for breast cancer. PURPOSE: This randomized phase III trial is studying goserelin to see how well it works compared with no goserelin in preventing early menopause in premenopausal women undergoing chemotherapy for stage I, stage II, or stage III breast cancer.

Timeline

Start
2004-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified — Subcutaneous
Background Cyclophosphamide Other / unclassified — —

Indications

breast cancer infertility disorder premature menopause